Ana Nordberg
11 – 20 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Creative Machines, Orphan Inventions: AI and the concept of inventor at the EPO
2022) p.159-180(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Governing, Protecting, and Regulating the Future of Genome Editing : The Significance of ELSPI Perspectives
(
- Contribution to journal › Scientific review
-
Mark
Genome editing in humans : A survey of law, regulation and governance principles
2022)(
- Book/Report › Report
-
Mark
Balancing innovation, ‘ordre public’ and morality in human germline editing : A call for more nuanced approaches in patent law
(
- Contribution to journal › Article
-
Mark
Governing, protecting, and regulating the future of genome editing : The significance of ELSI perspectives
(
- Contribution to journal › Article
- 2021
-
Mark
Biobank and Biomedical Research: Responsibilities of Controllers and Processors under the EU General Data Protection Regulation
2021) p.61-89(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
General commentary on 'A series of scenarios developed by the World Health Organization (WHO) Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing to both test the utility of, and illustrate how to use, their governance framework'
2021)(
- Other contribution › Consultation response
-
Mark
Big Science, Big Data, Big Innovation? : ERIC Policies on IP, Data and Technology Transfer
2021) p.65-106(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper
2021)(
- Book/Report › Report
-
Mark
Sweden: Legal Response to Covid-19
2021)(
- Chapter in Book/Report/Conference proceeding › Book chapter